Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 333 (LINC00333)
- Target
- LINC00333
- Molecular classification
- Long non-coding RNA, Intergenic non-coding RNA, Non-protein coding RNA
01
Overview
Long intergenic non-protein coding RNA 333 (LINC00333) is a non-coding RNA gene located in the human genome. It belongs to the long intergenic non-coding RNA (lincRNA) family, which comprises RNA molecules transcribed from regions outside of protein-coding genes and longer than 200 nucleotides[1][3][5][7]. LINC00333, like other lincRNAs, is thought to participate in the regulation of gene expression and chromatin structure. The specific biological functions, regulation, disease associations, and mechanistic actions of LINC00333 remain unclear due to limited functional characterization. It is not currently recognized as a therapeutic target, nor are there approved drugs or clinical interventions involving this molecule.
- Other names
- NCRNA00333
02
Mechanism of action
Not applicable (no drugs known to interact)
03
Biological functions
Likely involved in regulation of gene expression (inferred from general lincRNA function, not specific for LINC00333)Chromatin remodeling (general lincRNA function)Transcription regulation (general lincRNA function)RNA stabilization (general lincRNA function)The specific biological function of LINC00333 itself is currently uncharacterized in detail
04
Disease associations
No well-established disease associations or roles for LINC00333 have been reported in searchable literatureGeneral lincRNAs can play roles in cancer, developmental disease, and epigenetic disorders, but there is no direct evidence for LINC00333
05
Biomarkers
None established as patient selection or efficacy biomarkers for LINC00333.Some lincRNAs are studied as biomarkers in oncology and other diseases, but LINC00333 itself is not yet reported in this role.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 333 (LINC00333).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 333 (LINC00333).